Dating of human bocavirus infection with protein-denaturing IgG-avidity assays-Secondary immune activations are ubiquitous in immunocompetent adults

Journal of Clinical Virology

Volumn 48, Issue 1, 2010, Pages 44-48

  Hedman, Lea ^a,b   Söderlund Venermo, Maria ^a   Jartti, Tuomas ^c   Ruuskanen, Olli ^c   Hedman, Klaus ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anamnestic response; Antibody affinity; Immunoglobulin; Parvovirus; Serodiagnosis

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; PROTEIN VP2;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; HUMAN BOCAVIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DENATURATION; SCHOOL CHILD; SECONDARY INFECTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS INFECTION; VIRUS LIKE AGENT;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMAN BOCAVIRUS; HUMANS; IMMUNOCOMPETENCE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; PARVOVIRIDAE INFECTIONS; PROTEIN DENATURATION; SENSITIVITY AND SPECIFICITY; UREA; VIRION;

EID: 77950593199     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.02.003     Document Type: Article

References (45)

1. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102 (2005) 12801-12805
2. Schildgen O., Müller A., Allander T., Mackay I.M., Völz S., Kupfer B., et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections?. Clin Microbiol Rev 21 (2008) 291-304
3. Allander T., Jartti T., Gupta S., Niesters H.G., Lehtinen P., Österback R., et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 44 (2007) 904-910
4. Lin F., Zeng A., Yang N., Lin H., Yang E., Wang S., et al. Quantification of human bocavirus in lower respiratory tract infections in China. Infect Agent Cancer 2 (2007) 3
5. Choi J.H., Chung Y.S., Kim K.S., Lee W.J., Chung I.Y., Oh H.B., et al. Development of real-time PCR assays for detection and quantification of human bocavirus. J Clin Virol 42 (2008) 249-253
6. Jacques J., Moret H., Renois F., Lévêque N., Motte J., and Andréoletti L. Human Bocavirus quantitative DNA detection in French children hospitalized for acute bronchiolitis. J Clin Virol 43 (2008) 142-147
7. Kahn J.S., Kesebir D., Cotmore S., D'Abramo Jr. A., Cosby C., Weibel C., et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles. J Infect Dis 198 (2008) 41-50
8. Lin F., Guan W., Cheng F., Yang N., Pintel D., and Qiu J. ELISAs using human bocavirus VP2 virus-like particles for detection of antibodies against HBoV. J Virol Methods 149 (2008) 110-117
9. Zhao L.Q., Qian Y., Zhu R.N., Deng J., Wang F., Dong H.J., Sun Y., and Li Y. Human bocavirus infections are common in Beijing population indicated by sero-antibody prevalence analysis. Chin Med J (Engl) 122 (2009) 1289-1292
10. Cecchini S., Negrete A., Virag T., Graham B.S., Cohen J.I., and Kotin R.M. Evidence of prior exposure to human bocavirus as determined by a retrospective serological study of 404 serum samples from adults in the United States. Clin Vaccine Immunol 16 (2009) 597-604
11. Shirkoohi R., Endo R., Ishiguro N., Teramoto S., Kikuta H., and Ariga T. Antibodies against structural (VP1 and VP2) and nonstructural (NP-1 and NS1) proteins of human bocavirus in human sera. Clin Vaccine Immunol 17 (2010) 190-193
12. Kantola K., Hedman L., Allander T., Jartti T., Lehtinen P., Ruuskanen O., Hedman K., and Söderlund-Venermo M. Serodiagnosis of human bocavirus infections. Clin Infect Dis 46 (2008) 540-546
13. Lindner J., Karalar L., Zehentmeier S., Plentz A.S., Pfister H., Struff W., et al. Humoral immune response against human bocavirus VP2 virus-like particles. Viral Immunol 21 (2008) 443-449
14. Söderlund-Venermo M., Lahtinen A., Jartti T., Hedman L., Kemppainen K., Lehtinen P., Allander T., Ruuskanen O., and Hedman K. Bocavirus-induced wheezing in children: clinical assessment and improved diagnosis by serology. Emerg Infect Dis 15 (2009) 1423-1430
15. Don M., Söderlund-Venermo M., Valent F., Lahtinen A., Hedman L., Canciani M., et al. Serologically verified human bocavirus pneumonia in children. Pediatr Pulmonol 45 (2010) 120-126
16. Jartti T., Lehtinen P., Vuorinen T., et al. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 10 (2004) 1095-1101
17. Kaikkonen L., Lankinen H., Harjunpää I., Hokynar K., Söderlund-Venermo M., Oker-Blom C., Hedman L., and Hedman K. Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol 37 (1999) 3952-3956
18. Hedman K., Lappalainen M., Seppälä I., and Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159 (1989) 736-740
19. Korhonen M.H., Brunstein J., Haario H., Katnikov A., Rescaldani R., and Hedman K. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol 6 (1999) 725-728
20. Hedman K., and Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 8 (1988) 214-221
21. Söderlund M., Brown C.S., Cohen B.J., and Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 171 (1995) 710-713
22. Söderlund M., Brown C.S., Spaan W.J.M., Hedman L., and Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172 (1995) 1431-1436
23. Inouye S., Hasegawa A., Matsuno S., and Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 20 (1984) 525-529
24. Thomas H.I., and Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 101 (1988) 591-598
25. Polanec J., Seppälä I., Rousseau S., and Hedman K. Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus. J Clin Lab Anal 8 (1994) 16-21
26. von Linstow M.L., Høgh M., and Høgh B. Clinical and epidemiologic characteristics of human bocavirus in Danish infants: results from a prospective birth cohort study. Pediatr Infect Dis J 27 (2008) 897-902
27. Brieu N., Guyon G., Rodière M., Segondy M., and Foulongne V. Human bocavirus infection in children with respiratory tract disease. Pediatr Infect Dis J 27 (2008) 969-973
28. Blessing K., Neske F., Herre U., Kreth H.-W., and Weissbrich B. Prolonged detection of human bocavirus DNA in nasopharyngeal aspirates of children with respiratory tract disease. Pediatr Infect Dis J 28 (2009) 1018-1019
29. Wang K., Wang W., Yan H., Ren P., Zhang J., Sheng J., et al. Correlation between human bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection. J Clin Virol 47 (2010) 148-155
30. Manning A., Willey S.J., Bell J.E., and Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195 (2007) 1345-1352
31. Kuethe F., Lindner J., Matschke K., Wenzel J.J., Norja P., Ploetze K., et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49 (2009) 1660-1666
32. Norja P., Hokynar K., Aaltonen L.-M., Chen R., Ranki A., Partio E.K., et al. Bioportfolio: life-long persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103 (2006) 7450-7453
33. Simmonds P., Manning A., Kenneil R., Carnie F.W., and Bell J.E. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 13 (2007) 1386-1388
34. Longhi E., Bestetti G., Acquaviva V., Foschi A., Piolini R., Meroni L., Magni C., Antinori S., Parravicini C., and Corbellino M. Human parvovirus 4 in the bone marrow of Italian patients with AIDS. AIDS 21 (2007) 1481-1483
35. Schneider B., Fryer J.F., Reber U., Fischer H.P., Tolba R.H., Baylis S.A., and Eis-Hübinger A.M. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 80 (2008) 345-351
36. Lee H.W., and Scherer W.F. The anamnestic antibody response to Japanese encephalitis virus in monkeys and its implications concerning naturally acquired immunity in man. J Immunol 86 (1961) 151-164
37. Lennette E.H., Jensen F.W., Guenther R.W., and Magoffin R.L. Serologic responses to para-influenza viruses in patients with mumps virus injection. J Lab Clin Med 61 (1963) 780-788
38. Lehtonen O.P., and Meurman O.H. Avidity of IgG antibodies against mumps, parainfluenza 2 and Newcastle disease viruses after mumps infection. J Virol Meth 14 (1986) 1-7
39. Monath T.P., Guirakhoo F., Nichols R., Yoksan S., Schrader R., Murphy C., et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity. effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 188 (2003) 1213-1230
40. Thomas S.J., Strickman D., and Vaughn D.W. Dengue epidemiology: virus epidemiology, ecology and emergence. Adv Virus Res 61 (2003) 235-289
41. Kapoor A., Slikas E., Simmonds P., Chieochansin T., Naeem A., Shaukat S., et al. A newly identified bocavirus species in human stool. J Infect Dis 199 (2009) 196-200
42. Arthur J.L., Higgins G.D., Davidson G.P., Givney R.C., and Ratcliff R.M. A novel bocavirus associated with acute gastroenteritis in Australian children. PLoS Pathog 5 (2009) e1000391
43. Kapoor A, Simmonds P, Slikas B, Li L, Bodhidatta L, Sethabutr O, et al. Human bocaviruses are genetically diverse, dispersed, and highly prevalent enteric infections. J Infect Dis; in press.
44. Enders M., Schalasta G., Baisch C., Weidner A., Pukkila L., Kaikkonen L., Lankinen H., Hedman L., Söderlund-Venermo M., and Hedman K. Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics. J Clin Virol 35 (2006) 400-406
45. Ekman A., Hokynar K., Kakkola L., Kantola K., Hedman L., Bondén H., et al. Biological and immunological relation of human parvovirus B19 genotypes 1-3. J Virol 81 (2007) 6927-6935